Jay C. Buckey Jr, MD
Professor of Medicine
Director, Space Medicine Innovations Laboratory at Dartmouth
Adjunct Professor, Thayer School of Engineering
Cornell University, BSEE 1977
Cornell University Medical College, MD 1981
Geisel School of Medicine at Dartmouth
One Medical Center Dr.
Lebanon NH 03756
Central auditory processing as a marker of neurocognitive function
Space physiology and medicine
Audiology, hearing assessment
Computer-based psychological training and treatment programs
Visual changes after spaceflight
Virtual reality applications
The Space Medicine Innovations Laboratory is a multidisciplinary research lab with a global reach.
The lab’s current areas of research are:
• Assessing brain function using the brain’s auditory system in people with various conditions (HIV, Zika, Parkinson’s and Alzheimer’s).
• Developing new audiological tests for use both in the US and the developing world.
• Testing and developing self-directed, autonomous, interactive-media-based behavioral health tools and virtual reality for use in isolated and confined environments (e.g. Antarctic stations) and other settings.
• Use of hyperbaric oxygen for research and clinical applications.
• Other technology/science projects for NASA/Department of Defense – Previous areas of interest have included motion sickness, space-related bone loss, visual changes in astronauts, noise-induced hearing loss.
Space Physiology from Oxford University Press
The Neurolab Spacelab Mission: Neuroscience Research in Space
Results from the STS-90, Neurolab Spacelab Mission
Reliability of Tablet-Based Hearing Testing in Nicaraguan Schoolchildren: A Detailed Analysis.
Intranasal Scopolamine for Motion Sickness.
Use of Gases to Treat Cochlear Conditions.
Hearing complaints in HIV infection originate in the brain not the ear.
Application of SPOT chip for transcutaneous oximetry.
Transcutaneous oxygen measurement in humans using a paramagnetic skin adhesive film.
Portable Autorefractors for Detecting Axial Length Changes in Space.
Microgravity-induced ocular changes are related to body weight.
Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial.
Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes.